Optical Diagnostic Developer, Mela Sciences, Appoints Veteran Medical Device Investment Banker, Samuel Navarro, As Director

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

MELA Sciences, Inc. (NASDAQ: MELA), developer of MelaFind®, an FDA approved optical diagnostic device that assists dermatologists in melanoma diagnosis, today announced the appointment of veteran medical device investment banker Samuel E. Navarro to the Board of Directors. Mr. Navarro’s appointment brings MELA’s Board to eight members.

Help employers find you! Check out all the jobs and post your resume.

Back to news